Drug information for SODIUM IODIDE I 131

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 0.8-100mCi Discontinued   SODIUM IODIDE I-131 Iodine Radioisotopes MALLINCKRODT 16515
2012-02-07 Letter
2012-02-06 Label
CAPSULE; ORAL 0.8-100mCi Prescription  (Reference Drug) SODIUM IODIDE I-131 Iodine Radioisotopes MALLINCKRODT 16517
2012-02-07 Letter
2012-02-06 Label
CAPSULE; ORAL 15-100uCi Discontinued   SODIUM IODIDE I-131 Iodine Radioisotopes MALLINCKRODT   "
CAPSULE; ORAL 100uCi Discontinued   SODIUM IODIDE I-131 Iodine Radioisotopes CIS 17316
CAPSULE; ORAL 50uCi Discontinued   SODIUM IODIDE I-131 Iodine Radioisotopes CIS   "
SOLUTION; ORAL 3.5-150mCi/VIAL Prescription  (Reference Drug) SODIUM IODIDE I-131 Iodine Radioisotopes MALLINCKRODT 16515
2012-02-07 Letter
2012-02-06 Label
SOLUTION; ORAL 50mCi/ML Discontinued   SODIUM IODIDE I-131 Iodine Radioisotopes CIS 17315

Drug Adverse Effects information for SODIUM IODIDE I 131

Role code Indications Reaction # Reports
PS BASEDOW'S DISEASE HYPOTHYROIDISM 157
PS HAEMATOPOIETIC STEM CELL MOBILISATION DRUG INTERACTION 2
PS HAEMATOPOIETIC STEM CELL MOBILISATION PANCYTOPENIA 2
PS METASTASES TO BONE DRUG INTERACTION 1
PS METASTASES TO BONE PANCYTOPENIA 1
PS RADIOACTIVE IODINE THERAPY DACRYOSTENOSIS ACQUIRED 1
PS RADIOACTIVE IODINE THERAPY FALSE POSITIVE INVESTIGATION RESULT 1
PS RADIOACTIVE IODINE THERAPY PERITONEAL CYST 1
PS THYROID CANCER HYPOCALCAEMIA 1
PS THYROID CANCER HYPOKALAEMIA 1
PS THYROID CANCER HYPONATRAEMIA 1
PS THYROID CANCER HYPOPARATHYROIDISM 1
PS THYROID CANCER HYPOPHOSPHATAEMIA 1
PS THYROID CANCER HYPOTHYROIDISM 1
PS THYROID CANCER INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1
PS THYROID CANCER METABOLIC ALKALOSIS 1
PS THYROID CANCER PULMONARY FIBROSIS 5
PS THYROID CANCER RESPIRATORY FAILURE 1
PS THYROID CANCER METASTATIC BONE MARROW FAILURE 2
PS THYROID CANCER METASTATIC RADIATION PNEUMONITIS 5
PS THYROID CANCER METASTATIC SEPSIS 2
PS THYROID CANCER METASTATIC VOMITING 1
PS THYROID THERAPY DRUG INEFFECTIVE 1
PS THYROID THERAPY HYPOTHYROIDISM 8
PS TOXIC NODULAR GOITRE DRUG INEFFECTIVE 1
PS TOXIC NODULAR GOITRE HYPOTHYROIDISM 8
SS HAEMATOPOIETIC STEM CELL MOBILISATION DRUG INTERACTION 8
SS HAEMATOPOIETIC STEM CELL MOBILISATION PANCYTOPENIA 8
SS IODINE UPTAKE CYANOSIS 1
SS IODINE UPTAKE HYPERSENSITIVITY 1
SS IODINE UPTAKE HYPOAESTHESIA 1
SS IODINE UPTAKE RASH MACULAR 1
SS METASTASES TO BONE DRUG INTERACTION 4
SS METASTASES TO BONE PANCYTOPENIA 4
SS SCAN THYROID GLAND CYANOSIS 1
SS SCAN THYROID GLAND HYPERSENSITIVITY 1
SS SCAN THYROID GLAND HYPOAESTHESIA 1
SS SCAN THYROID GLAND RASH MACULAR 1
SS THYROID CANCER HYPOCALCAEMIA 1
SS THYROID CANCER HYPOKALAEMIA 1
SS THYROID CANCER HYPONATRAEMIA 1
SS THYROID CANCER HYPOPARATHYROIDISM 1
SS THYROID CANCER HYPOPHOSPHATAEMIA 1
SS THYROID CANCER HYPOTHYROIDISM 1
SS THYROID CANCER INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1
SS THYROID CANCER METABOLIC ALKALOSIS 1
Ads by Google